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disorders. The anti-asthma drugs have a choice 
position, but chemotherapy for lung cancers and 
antibiotics are also studied. As the book has been 
written from a pharmacological point of view, the 
treatment of asthma (for example) is analytical; there 
is no synthesis and no strategy (it is not the aim of the 
book). 
One of the best qualities of Drugs and the Jung 
is the large quantity of references: 651 for gluco- 
corticosteroids. They are analysed and discussed in 
depth. 
In the second section (seven chapters out of 16), 
drugs which are under investigation are discussed. 
The so-called ‘anti-leukotrienes’ (antagonists and 
inhibitors) have only a brief mention. Zileuton is 
close to being marketed and is more promising than 
PAF-antagonists (at least in the very near future). 
There is no mention of gene therapy. 
This book is well-documented and should be of 
great interest to clinicians and students. 
/?-agonists are the subject of the first chapter 
(glucocorticosteroids could have been another good 
choice to emphasize its importance). The mechanism 
of action is briefly summarized and it is quite surpris- 
ing to note that the effects of &agonists on inflam- 
matory cells have been discussed in depth, as 
compared to their effects on smooth muscles. The 
regular use of &agonists in asthmatics has been 
clearly discussed: the conclusion is that this subject is 
highly controversial but the author suggests their use 
on a pm basis. However, the new long-acting 
&agonists (by inhalation and per OS) could modify 
the strategy and will have to be evaluated completely. 
Anti-cholinergic therapy has been clearly reviewed 
by Professor P. Barnes. The understanding of the 
receptor subtype is very important: hence six 
explanatory figure in this short chapter. 
Xanthines are the object of some controversy and I 
would like to add my contribution: the authors 
forgot to mention that Laennec also recommended to 
his patients to drink coffee! More seriously, it is very 
surprising that the mechanism of action is so badly 
understood. The authors performed several works 
and suggest that theophylline could have anti- 
inflammatory properties. I would also like to add my 
personal contribution, based on my daily clinical 
expertise; most of the asthmatics who tolerate theo- 
phylline are very compliant to this drug and their 
asthma worsens if they stop (for any reason). 
The chapter on glucocorticosteroids is probably 
the most interesting, as well as the longest (more than 
100 pages). All the aspects of these unique drugs have 
been developed in depth. The authors have been able 
to explain clearly the mechanisms of action from the 
DNA site to the patient..The treatment of asthma 
is discussed, as expected, but also the other lung 
disorders. 
Prophylactic anti-asthma drugs (cromoglycate and 
nedocromil) are the subject of a specific chapter, 
which also includes anti-histamines. These are clearly 
indicated in the treatment of rhinitis, and not in 
asthma. However, the improvement of the rhinitis 
could have some effect on the airways. This aspect 
could have been discussed. 
One chapter has been entitled ‘immunosuppressive 
agents’. In fact it should have been entitled ‘steroid 
sparing drugs’, because all these indications have 
been used with this objective and because the mech- 
anism of action is the subject of controversy. 
The chapter on chemotherapy in lung cancer 
aims to define the respective place of chemotherapy, 
radiation therapy, immunotherapy and surgery in the 
treatment of both small cell and non-small cell lung 
cancers. 
It is noteworthy that dealing with such an extensive 
topic in a very limited place is a real challenge. From 
this point of view, this is a good chapter. However, 
there are some weaknesses. It might be interesting to 
emphasize recent advances, such as: 
- Mixed small cell-non-small lung cancer; 
-Negative survival effect of slight dose reduction 
during the first cycle of SCLC chemotherapy; 
-Use of cytokines as maintenance therapy in 
responder SCLC patients (at least, to say that the 
studies are, at that point, negative); 
- Prognostic effect of combined chemotherapy- 
radiation therapy in limited small cell lung cancer; 
- Timing of radiation therapy in combined modality 
treatment; and 
- Recommendations on use of haematopoietic 
growth factor as adjunct to SCLC chemotherapy. 
J. L. PujoJ and PH Godard 
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Biopsy interpretation of the Jung by Shimosato and 
Miller is a volume in the Biopsy Interpretation Series 
by Raven Press. It is a small book compared with 
several very extensive new additions of lung pathol- 
ogy books published within the last couple of years. 
But it is good! 
Part I (11 chapters) deals with infiltrative lung 
disease and Part II (14 chapters) with benign and 
malignant tumours (including those of pleura). 
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In general, the book is well written and logically 
structured. I think it is relevant and sound judgement 
that the authors stress again and again that a diag- 
nosis is best achieved when one combines clinical 
aspects with the results of other investigations, 
including biopsy. In particular, Part I clearly states 
that biopsy is not always indicated-something 
which authors of pathology books sometimes tend to 
forget to write about. The authors are also level- 
headed when discussing differential diagnoses. 
Only regarding benign nodular epithelial tumour of 
bronchioloalveolar region/papillary adenoma of type 
II pneumocyteslsclerosing hemangioma (type II 
pneumocytom) and the crucial question: is it benign/ 
malignant, do I think the text pretends more than 
reality holds. 
Although a small book, relevant information is 
present on modern thoughts of pathogenesis and 
methodologies (especially immunohistochemistry). 
The figures are black and white but of extremely 
good quality and relevance. I can just tolerate the 
many abbreviations - it saves space, but actually they 
are somewhat disturbing and irritating. The refer- 
ences are generally relevant and new, and the index is 
adequate. 
This textbook on biopsy interpretation of lung 
pathology will be of daily use in many practices. It is 
composed in a classical way, no fuss, but is well done, 
succinct and to the point. In my opinion, it is a good 
buy at a sensible price. 
U. Baandrup 
